Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Gadi D, Griffith A, Wang Z, Tyekucheva S, et al. Idelalisib reduces regulatory T cells and activates T helper 17 cell differentiation in relapsed refractory patients with chronic lymphocytic leukaemia. Br J Haematol 2022;197:207-211.
PMID: 35170759


Privacy Policy